Perceived organizational support moderates the effect of job demands on outcomes: Testing the JD-R model in Italian oncology nurses
2024-01-01 Ramaci, Tiziana; Santisi, Giuseppe; Curatolo, Krizia; Barattucci, Massimiliano
Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study
2007-01-01 Gridelli, C; Gallo, C; Ceribelli, A; Gebbia, V; Gamucci, T; Ciardiello, F; Carozza, F; Favaretto, A; Daniele, B; Galetta, D; Barbera, S; Rosetti, F; Rossi, A; Maione, P; Cognetti, F; Testa, A; DI MAIO, M; Morabito, A; Perrone, F; Geco, Investigators
Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study
2007-01-01 Gridelli, C; Ferrara, C; Guerriero, C; Palazzo, S; Grasso, G; Pavese, I; Satta, F; Bajetta, E; Cortinovis, D; Barbieri, F; Gebbia, V; Grossi, F; Novello, S; Baldini, E; Gasparini, G; Latino, W; Durante, E; Giustini, L; Negrini, C
Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice
2007-01-01 Gebbia, V; Maiello, E; Giuliani, F; Borsellino, N; Caruso, M; DI MAGGIO, G; Ferrau, F; Bordonaro, R; Verderame, F; Tralongo, P; DI CRISTINA, L; Agueli, R; Russo, P; Colucci, G
Cetuximab in squamous cell head and neck carcinomas
2007-01-01 Gebbia, V; Giuliani, G; Valori, Vm; Agueli, R; Colucci, G; Maiello, E
Cetuximab: clinical results in colorectal cancer
2007-01-01 Maiello, E; Giuliani, F; Gebbia, V; Piano, A; Agueli, R; Colucci, G
Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study)
2007-01-01 DE VITA, F; Giuliani, F; Orditura, M; Maiello, E; Galizia, G; DI MARTINO, N; Montemurro, F; Carteni, G; Manzione, L; Romito, S; Gebbia, V; Ciardiello, F; Catalano, G; Colucci, G; GRUPPO ONCOLOGICO ITALIA, Meridionale
Thyroglossal duct cyst carcinoma with concurrent thyroid carcinoma: a case report. J Med Case Reports. 2008 Apr 29;2:132
2008-01-01 Gebbia, V; DI GREGORIO, C; Attard, M
Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer?
2008-01-01 Gebbia, V
Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale)
2008-01-01 Gebbia, V; Galetta, D; Lorusso, V; Caruso, M; Verderame, F; Pezzella, G; Borsellino, N; Durini, E; Valenza, R; Agostara, B; Colucci, G; GRUPPO ONCOLOGICO ITALIA, Meridionale
Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management
2008-01-01 Mercadante, S; Porzio, G; Ferrera, P; Fulfaro, F; Aielli, F; Verna, L; Villari, P; Ficorella, C; Gebbia, V; Riina, S; Casuccio, A; Mangione, S
[First line chemotherapy in non-small cell lung carcinoma: a solved dilemma]
2008-01-01 Gebbia, Vittorio
Adjuvant Therapy in Colon Cancer
2009-01-01 Lombardi, L; Gebbia, V; Silvestris, N; Testa, A; Colucci, G; Maiello, E
Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer
2009-01-01 Gebbia, V; Mancuso, G; Lombardi, L; Maiello, E
Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option?
2009-01-01 Galetta, D; Rossi, A; Colucci, G; Gebbia, V
Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial
2009-01-01 Gebbia, V; Gridelli, C; Verusio, C; Frontini, L; Aitini, E; Daniele, B; Gamucci, T; Mancuso, G; DI MAIO, M; Gallo, C; Perrone, F; Morabito, A
Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer
2009-01-01 Di Maio, M; Chiodini, P; Georgoulias, V; Hatzidaki, D; Takeda, K; Wachters, Fm; Gebbia, V; Smit, Ef; Morabito, A; Gallo, C; Perrone, F; Gridelli, C.
Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines
2009-01-01 Vici, P; Giotta, F; DI Lauro, L; Brandi, M; Gebbia, V; Foggi, P; Lorusso, V; Vitucci, C; Sergi, D; Fattoruso, Si; Giannarelli, D; Viola, G; Corsetti, S; Colucci, G; Lopez, M.
Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients
2009-01-01 Mercadante, S; Gebbia, V; David, F; Aielli, F; Verna, L; Casuccio, A; Porzio, G; Mangione, S; Ferrera, P.
A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial
2009-01-01 Pisano, C; Morabito, A; Sorio, R; Breda, E; Lauria, R; Gebbia, V; Scaltriti, L; Scalone, S; Zagonel, V; Greggi, S; Beneduce, G; Losito, S; Gallo, C; Di Maio, M; Forestieri, V; Pignata, S.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Perceived organizational support moderates the effect of job demands on outcomes: Testing the JD-R model in Italian oncology nurses | 1-gen-2024 | Ramaci, Tiziana; Santisi, Giuseppe; Curatolo, Krizia; Barattucci, Massimiliano | |
| Factorial phase III randomised trial of rofecoxib and prolonged constant infusion of gemcitabine in advanced non-small-cell lung cancer: the GEmcitabine-COxib in NSCLC (GECO) study | 1-gen-2007 | Gridelli, C; Gallo, C; Ceribelli, A; Gebbia, V; Gamucci, T; Ciardiello, F; Carozza, F; Favaretto, A; Daniele, B; Galetta, D; Barbera, S; Rosetti, F; Rossi, A; Maione, P; Cognetti, F; Testa, A; DI MAIO, M; Morabito, A; Perrone, F; Geco, Investigators | |
| Informal caregiving burden in advanced non-small cell lung cancer: the HABIT study | 1-gen-2007 | Gridelli, C; Ferrara, C; Guerriero, C; Palazzo, S; Grasso, G; Pavese, I; Satta, F; Bajetta, E; Cortinovis, D; Barbieri, F; Gebbia, V; Grossi, F; Novello, S; Baldini, E; Gasparini, G; Latino, W; Durante, E; Giustini, L; Negrini, C | |
| Second-line chemotherapy in advanced pancreatic carcinoma: a multicenter survey of the Gruppo Oncologico Italia Meridionale on the activity and safety of the FOLFOX4 regimen in clinical practice | 1-gen-2007 | Gebbia, V; Maiello, E; Giuliani, F; Borsellino, N; Caruso, M; DI MAGGIO, G; Ferrau, F; Bordonaro, R; Verderame, F; Tralongo, P; DI CRISTINA, L; Agueli, R; Russo, P; Colucci, G | |
| Cetuximab in squamous cell head and neck carcinomas | 1-gen-2007 | Gebbia, V; Giuliani, G; Valori, Vm; Agueli, R; Colucci, G; Maiello, E | |
| Cetuximab: clinical results in colorectal cancer | 1-gen-2007 | Maiello, E; Giuliani, F; Gebbia, V; Piano, A; Agueli, R; Colucci, G | |
| Adjuvant chemotherapy with epirubicin, leucovorin, 5-fluorouracil and etoposide regimen in resected gastric cancer patients: a randomized phase III trial by the Gruppo Oncologico Italia Meridionale (GOIM 9602 Study) | 1-gen-2007 | DE VITA, F; Giuliani, F; Orditura, M; Maiello, E; Galizia, G; DI MARTINO, N; Montemurro, F; Carteni, G; Manzione, L; Romito, S; Gebbia, V; Ciardiello, F; Catalano, G; Colucci, G; GRUPPO ONCOLOGICO ITALIA, Meridionale | |
| Thyroglossal duct cyst carcinoma with concurrent thyroid carcinoma: a case report. J Med Case Reports. 2008 Apr 29;2:132 | 1-gen-2008 | Gebbia, V; DI GREGORIO, C; Attard, M | |
| Does an optimal therapeutic sequence exist in advanced non-small cell lung cancer? | 1-gen-2008 | Gebbia, V | |
| Cisplatin plus weekly vinorelbine versus cisplatin plus vinorelbine on days 1 and 8 in advanced non-small cell lung cancer: a prospective randomized phase III trial of the G.O.I.M. (Gruppo Oncologico Italia Meridionale) | 1-gen-2008 | Gebbia, V; Galetta, D; Lorusso, V; Caruso, M; Verderame, F; Pezzella, G; Borsellino, N; Durini, E; Valenza, R; Agostara, B; Colucci, G; GRUPPO ONCOLOGICO ITALIA, Meridionale | |
| Sustained-release oral morphine versus transdermal fentanyl and oral methadone in cancer pain management | 1-gen-2008 | Mercadante, S; Porzio, G; Ferrera, P; Fulfaro, F; Aielli, F; Verna, L; Villari, P; Ficorella, C; Gebbia, V; Riina, S; Casuccio, A; Mangione, S | |
| [First line chemotherapy in non-small cell lung carcinoma: a solved dilemma] | 1-gen-2008 | Gebbia, Vittorio | |
| Adjuvant Therapy in Colon Cancer | 1-gen-2009 | Lombardi, L; Gebbia, V; Silvestris, N; Testa, A; Colucci, G; Maiello, E | |
| Evolution of Therapy Decision-Making Process for Advanced Non-Small Cell Lung Cancer | 1-gen-2009 | Gebbia, V; Mancuso, G; Lombardi, L; Maiello, E | |
| Third-line therapy for advanced non-small-cell lung cancer patients: a feasible therapeutic option? | 1-gen-2009 | Galetta, D; Rossi, A; Colucci, G; Gebbia, V | |
| Weekly docetaxel vs. docetaxel-based combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer patients. The DISTAL-2 randomized trial | 1-gen-2009 | Gebbia, V; Gridelli, C; Verusio, C; Frontini, L; Aitini, E; Daniele, B; Gamucci, T; Mancuso, G; DI MAIO, M; Gallo, C; Perrone, F; Morabito, A | |
| Meta-analysis of single-agent chemotherapy compared with combination chemotherapy as second-line treatment of advanced non-small-cell lung cancer | 1-gen-2009 | Di Maio, M; Chiodini, P; Georgoulias, V; Hatzidaki, D; Takeda, K; Wachters, Fm; Gebbia, V; Smit, Ef; Morabito, A; Gallo, C; Perrone, F; Gridelli, C. | |
| Multicenter phase II trial of first-line docetaxel/gemcitabine in advanced breast cancer pretreated with adjuvant anthracyclines | 1-gen-2009 | Vici, P; Giotta, F; DI Lauro, L; Brandi, M; Gebbia, V; Foggi, P; Lorusso, V; Vitucci, C; Sergi, D; Fattoruso, Si; Giannarelli, D; Viola, G; Corsetti, S; Colucci, G; Lopez, M. | |
| Tools for identifying cancer pain of predominantly neuropathic origin and opioid responsiveness in cancer patients | 1-gen-2009 | Mercadante, S; Gebbia, V; David, F; Aielli, F; Verna, L; Casuccio, A; Porzio, G; Mangione, S; Ferrera, P. | |
| A phase II study of capecitabine in the treatment of ovarian cancer resistant or refractory to platinum therapy: a multicentre Italian trial in ovarian cancer (MITO-6) trial | 1-gen-2009 | Pisano, C; Morabito, A; Sorio, R; Breda, E; Lauria, R; Gebbia, V; Scaltriti, L; Scalone, S; Zagonel, V; Greggi, S; Beneduce, G; Losito, S; Gallo, C; Di Maio, M; Forestieri, V; Pignata, S. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista15361
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa17
- 2020 - 20267032
- 2010 - 20195807
- 2000 - 20091967
- 1990 - 1999480
- 1980 - 198960
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...225
- JOURNAL OF CLINICAL MEDICINE153
- CANCERS122
- INTERNATIONAL JOURNAL OF ENVIRONM...110
- LNS. ACTIVITY REPORT85
- PHD KORE REVIEW78
- DIAGNOSTICS77
- RIVISTA DELLA COOPERAZIONE GIURID...76
- SCIENTIFIC REPORTS73
- SUSTAINABILITY72
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19257
- Humans250
- Female133
- Male127
- SARS-CoV-2108
- inflammation103
- oxidative stress85
- Italy78
- Adult69
- Middle Aged67
Lingua
- eng10818
- ita2584
- fre66
- spa64
- lat12
- ger11
- por6
- ara3
- cat3
- enm2
Accesso al fulltext
- no fulltext15364